特发性扩张型心肌病患者心肌细胞中肠道病毒持续存在与5'端基因组RNA缺失及病毒蛋白酶活性相关
该研究从扩张型心肌病患者心肌组织提取RNA,鉴定出以5'端基因组RNA缺失(17-50个核苷酸)为主的B组肠道病毒持续形式,这些缺失型RNA可在原代人心肌细胞中早期复制并翻译出有活性的蛋白酶2A,混合形式可诱导细胞病变,提示病毒蛋白酶2A活性可能损害心肌细胞功能。
要点
- 扩张型心肌病患者心肌中持续存在5'端缺失17-50个核苷酸的B组肠道病毒RNA。
- 缺失型病毒RNA可在心肌细胞中早期复制并产生有蛋白水解活性的2A蛋白酶。
- 缺失型与全长RNA混合可诱导不同于全长 alone 的细胞病变效应。
核心结论
- 特发性扩张型心肌病患者心肌中持续的B组肠道病毒以5'端基因组RNA缺失形式存在,这些病毒单独或与全长辅助RNA共同通过2A蛋白酶活性损害心肌细胞功能。
研究设计与样本
- 从扩张型心肌病患者心肌组织提取总RNA,鉴定肠道病毒RNA 5'端序列,经下一代RNA测序后构建模拟患者组织病毒RNA序列的cDNA克隆,在原代人心脏细胞中评估复制及对宿主细胞功能的影响。
主要发现
- 主要B组肠道病毒群体以5'端基因组RNA缺失17至50个核苷酸为特征,可单独存在或与低比例完整5'端基因组末端共存。
- 原位杂交和免疫组化检测到这些持续基因组存在于成簇的心肌细胞中。
- 将病毒RNA转染原代人 cardiomyocytes 显示,缺失型基因组RNA在无可检测病毒蚀斑形成的情况下表现出早期复制活性,而缺失型与完整型混合产生的颗粒可诱导不同于单独全长型的细胞病变效应。
- 缺失型或全长型及混合型病毒RNA均能在人 cardiomyocytes 中指导翻译并产生有蛋白水解活性的病毒蛋白酶2A。
临床怎么用
- 对于不明原因扩张型心肌病,可考虑B组肠道病毒持续感染及5'端基因组RNA缺失形式的致病作用。
- 针对柯萨奇B组病毒蛋白酶2A活性的特异性抑制剂可能成为急性和慢性心脏感染的新治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Group B enteroviruses are common causes of acute myocarditis, which can be a precursor of chronic myocarditis and dilated cardiomyopathy, leading causes of heart transplantation. To date, the specific viral functions involved in the development of dilated cardiomyopathy remain unclear. METHODS: Total RNA from cardiac tissue of patients with dilated cardiomyopathy was extracted, and sequences corresponding to the 5' termini of enterovirus RNAs were identified. After next-generation RNA sequencing, viral cDNA clones mimicking the enterovirus RNA sequences found in patient tissues were generated in vitro, and their replication and impact on host cell functions were assessed on primary human cardiac cells in culture. RESULTS: Major enterovirus B populations characterized by 5' terminal genomic RNA deletions ranging from 17 to 50 nucleotides were identified either alone or associated with low proportions of intact 5' genomic termini. In situ hybridization and immunohistological assays detected these persistent genomes in clusters of cardiomyocytes. Transfection of viral RNA into primary human cardiomyocytes demonstrated that deleted forms of genomic RNAs displayed early replication activities in the absence of detectable viral plaque formation, whereas mixed deleted and complete forms generated particles capable of inducing cytopathic effects at levels distinct from those observed with full-length forms alone. Moreover, deleted or full-length and mixed forms of viral RNA were capable of directing translation and production of proteolytically active viral proteinase 2A in human cardiomyocytes. CONCLUSIONS: We demonstrate that persistent viral forms are composed of B-type enteroviruses harboring a 5' terminal deletion in their genomic RNAs and that these viruses alone or associated with full-length populations of helper RNAs could impair cardiomyocyte functions by the proteolytic activity of viral proteinase 2A in cases of unexplained dilated cardiomyopathy. These results provide a better understanding of the molecular mechanisms that underlie the persistence of EV forms in human cardiac tissues and should stimulate the development of new therapeutic strategies based on specific inhibitors of the coxsackievirus B proteinase 2A activity for acute and chronic cardiac infections.
引用
- Bouin A, Gretteau PA, Wehbe M, et al. Enterovirus Persistence in Cardiac Cells of Patients With Idiopathic Dilated Cardiomyopathy Is Linked to 5' Terminal Genomic RNA-Deleted Viral Populations With Viral-Encoded Proteinase Activities. Circulation. 2019. PMID: 30755025. doi:10.1161/CIRCULATIONAHA.118.035966
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。